Follow the Iconovo AB stock price and the full insider trade history of the company, a listed equity based in Finland. Shares are quoted on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Iconovo AB has recorded 17 public disclosures. Market capitalisation: €96.2m. The latest transaction was disclosed on 1 June 2026 (Purchase). Among the most active insiders: Johan Wäborg. All data is openly available.
17
Insider Decl.
n/a
Thresholds
€382,487
15 ops.
Buy Volume
€109,525
1 ops.
Sell Volume
34Σ signal
Buys €382,487€109,525 Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
300 shares@ SEK 50.44100.0% of flowAktieISINISIN SE0010868943FI:A001P307-1
17 of 17 declarations
Acerca de Iconovo AB
Iconovo AB es una empresa centrada en el desarrollo de fármacos inhalados y tecnologías de administración de fármacos. Cotiza en la bolsa de valores XSTO.